<DOC>
	<DOCNO>NCT00709423</DOCNO>
	<brief_summary>A number common eye diseases retinal artery vein occlusion , diabetic retinopathy , age-related macular degeneration , glaucoma anterior ischemic optic neuropathy associate ocular perfusion abnormality . Although well recognize much possibility improve blood flow posterior pole eye disease . Since many year , moxaverine use therapy perfusion abnormality brain , heart extremity . This base direct vasodilator effect drug , also rheological property red blood cell . Whether moxaverine affect blood flow eye unknown . The present study aim investigate whether moxaverine may improve blood flow eye systemic administration .</brief_summary>
	<brief_title>Effects Moxaverine Placebo Ocular Blood Flow</brief_title>
	<detailed_description />
	<mesh_term>Moxaverine</mesh_term>
	<mesh_term>Papaverine</mesh_term>
	<criteria>Men woman age 18 35 year , nonsmoker Body mass index 15th 85th percentile Normal finding medical history physical examination unless investigator considers abnormality clinically irrelevant Normal laboratory value unless investigator considers abnormality clinically irrelevant Normal ophthalmic finding , ametropy &lt; 3 dpt . Regular use medication , abuse alcoholic beverage drug , participation clinical trial 3 week precede study Treatment previous 3 week drug Symptoms clinically relevant illness 3 week first study day History presence gastrointestinal , liver kidney disease , condition know interfere distribution , metabolism excretion study drug Blood donation previous 3 week Ametropy &gt; = 3 dpt Acute gastric bleeding , massive cerebral hemorrhage relate stroke Women : pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>June 2008</verification_date>
</DOC>